BIOLASE (BIOL) Competitors $0.0087 0.00 (-8.42%) As of 02/20/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends BIOL vs. NVIVQ, DYNT, SONX, GCTK, SDCCQ, VRAYQ, AHPI, BRSH, MOTS, and VIVEShould you be buying BIOLASE stock or one of its competitors? The main competitors of BIOLASE include Invivo Therapeutics (NVIVQ), Dynatronics (DYNT), Sonendo (SONX), GlucoTrack (GCTK), SmileDirectClub (SDCCQ), ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Bruush Oral Care (BRSH), Motus GI (MOTS), and Viveve Medical (VIVE). These companies are all part of the "medical equipment" industry. BIOLASE vs. Invivo Therapeutics Dynatronics Sonendo GlucoTrack SmileDirectClub ViewRay Allied Healthcare Products Bruush Oral Care Motus GI Viveve Medical Invivo Therapeutics (NASDAQ:NVIVQ) and BIOLASE (NASDAQ:BIOL) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, community ranking, earnings and dividends. Do institutionals and insiders hold more shares of NVIVQ or BIOL? 12.3% of Invivo Therapeutics shares are owned by institutional investors. Comparatively, 8.8% of BIOLASE shares are owned by institutional investors. 2.5% of Invivo Therapeutics shares are owned by insiders. Comparatively, 0.3% of BIOLASE shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more volatility and risk, NVIVQ or BIOL? Invivo Therapeutics has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500. Comparatively, BIOLASE has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Does the media refer more to NVIVQ or BIOL? In the previous week, BIOLASE had 1 more articles in the media than Invivo Therapeutics. MarketBeat recorded 1 mentions for BIOLASE and 0 mentions for Invivo Therapeutics. Invivo Therapeutics' average media sentiment score of 0.00 equaled BIOLASE'saverage media sentiment score. Company Overall Sentiment Invivo Therapeutics Neutral BIOLASE Neutral Does the MarketBeat Community believe in NVIVQ or BIOL? BIOLASE received 292 more outperform votes than Invivo Therapeutics when rated by MarketBeat users. CompanyUnderperformOutperformInvivo TherapeuticsN/AN/ABIOLASEOutperform Votes29252.05% Underperform Votes26947.95% Do analysts recommend NVIVQ or BIOL? BIOLASE has a consensus target price of $1.20, suggesting a potential upside of 13,693.10%. Given BIOLASE's stronger consensus rating and higher probable upside, analysts plainly believe BIOLASE is more favorable than Invivo Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Invivo Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00BIOLASE 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Is NVIVQ or BIOL more profitable? Invivo Therapeutics has a net margin of 0.00% compared to BIOLASE's net margin of -41.65%. Invivo Therapeutics' return on equity of 0.00% beat BIOLASE's return on equity.Company Net Margins Return on Equity Return on Assets Invivo TherapeuticsN/A N/A N/A BIOLASE -41.65%-1,782.73%-55.31% Which has preferable valuation & earnings, NVIVQ or BIOL? Invivo Therapeutics has higher earnings, but lower revenue than BIOLASE. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInvivo TherapeuticsN/AN/A-$10.49MN/AN/ABIOLASE$48.83M0.01-$20.63M-$14.940.00 SummaryBIOLASE beats Invivo Therapeutics on 7 of the 13 factors compared between the two stocks. Get BIOLASE News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOL vs. The Competition Export to ExcelMetricBIOLASEDental equipment & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$291,000.00$3.90B$5.85B$9.15BDividend YieldN/A1.79%4.76%3.85%P/E Ratio0.005.5116.5114.19Price / Sales0.011.61450.0276.60Price / CashN/A6.5738.0134.95Price / Book-0.120.837.644.63Net Income-$20.63M-$146.24M$3.18B$245.69M7 Day PerformanceN/A1.54%-1.95%-2.68%1 Month PerformanceN/A0.13%-0.23%-2.16%1 Year PerformanceN/A217.04%16.69%12.90% BIOLASE Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOLBIOLASE0.9276 of 5 stars$0.01-8.4%$1.20+13,693.1%-93.9%$291,000.00$48.83M0.00160Gap UpNVIVQInvivo TherapeuticsN/A$0.37flatN/AN/A$1.15MN/A0.006High Trading VolumeDYNTDynatronicsN/A$0.13-9.9%N/A-74.0%$1.11M$32.53M-0.13200Analyst ForecastGap DownSONXSonendoN/A$2.54+18.0%N/A+1,398.2%$1.09M$43.87M-0.04250Gap UpGCTKGlucoTrack0.8358 of 5 stars$0.61-5.8%N/A-98.4%$484,000.00N/A-0.015Gap DownSDCCQSmileDirectClubN/A$0.00-25.0%N/A-96.0%$121,000.00$470.74M0.002,700Gap DownVRAYQViewRayN/AN/AN/AN/A$20,000.00$102.21M0.00300AHPIAllied Healthcare ProductsN/AN/AN/AN/A$16,000.00$27.05M0.00150Analyst ForecastGap UpBRSHBruush Oral CareN/A$0.00flatN/A-97.4%$1,000.00$2.92M0.0011MOTSMotus GIN/A$0.00-50.0%N/A-100.0%$1,000.00$319,000.000.0030VIVEViveve MedicalN/A$0.00-50.0%N/A+0.0%$1,000.00$6.83M0.0070Gap Down Related Companies and Tools Related Companies Invivo Therapeutics Alternatives Dynatronics Alternatives Sonendo Alternatives GlucoTrack Alternatives SmileDirectClub Alternatives ViewRay Alternatives Allied Healthcare Products Alternatives Bruush Oral Care Alternatives Motus GI Alternatives Viveve Medical Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BIOL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIOLASE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
